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Abstract,  A  fetal rat hepatocyte culture  system has 
been used to study the molecular mechanisms  of tyro- 
sine aminotransferase  (TAT) gene expression during 
development.  It has previously been shown that TAT 
activity can be detected in  19-d,  but not  15-d,  gesta- 
tion hepatocytes on the first day of culture (Yeoh, 
G.  C.  T.,  E  A.  Bennett,  and I.  T.  Oliver.  1979.  Bio- 
chem.  J.  180:153-160).  In this  study enzyme activity, 
synthesis,  and mRNA levels were determined  in hepa- 
tocytes isolated from  13-,  15-,  and  19-d gestation  rats 
maintained  in culture for  1, 2,  or 3 d  and exposed to 
dexamethasone.  TAT expression  is barely detectable in 
13-d gestation hepatocytes even after 3 d  in culture. 
Hepatocytes isolated from  15-d gestation fetuses have 
undetectable levels of enzyme activity and  synthesis on 
the first day of culture;  both can be assayed by days 2 
and 3.  TAT mRNA levels in these hepatocytes,  mea- 
sured by hybridization  with a  specific cDNA,  increase 
substantially  during culture.  TAT activity,  synthesis, 
and mRNA are evident on the first and subsequent 
days of culture in  19-d gestation hepatocytes.  Tran- 
scription  measurements  in isolated nuclei indicate that 
the increase  in TAT mRNA in  15- and  19-d gestation 
hepatocytes is associated with an  increase in transcrip- 
tion of the gene.  Immunocytochemical  studies demon- 
strated that the increase  in TAT expression correlated 
with an increase in the proportion  of hepatocytes ex- 
pressing the enzyme,  rather  than a  simultaneous  in- 
crease in all hepatocytes.  These results  support the 
proposal that a  subpopulation of 15-d fetal hepatocytes 
undergo differentiation  in culture with respect to TAT. 
T 
YROSINE aminotransferase  (TAT) ~ is one of a group 
of rat liver enzymes that first appears in the postnatal 
liver (12, 33). TAT expression is virtually absent in the 
fetus; enzyme activity (33) and mRNA (25, 26) accumulate 
shortly after birth when transcription of the gene is activated 
(26). Although inactive in the fetus, the TAT gene is capable 
of expression before birth. TAT activity can be precociously 
induced by in utero injection of glucagon or dibutyryl cAMP 
(13, 25, 27), premature delivery of the fetus (19), as well as 
in fetal liver explants (27, 28, 35) or monolayer cultures (36). 
It is suggested that fetal hepatocytes undergo a differentiative 
event before birth  rendering  the TAT  gene potentially  ex- 
pressible (36).  The absence of expression during gestation 
is probably due to an  inhibitory  component(s)  within  the 
uterine environment  (3,  18, 25). 
To study TAT expression in fetal liver, a hepatocyte culture 
system,  which has been shown to be suitable for enzyme 
production in competent bepatocytes, was used (36). Dexa- 
methasone, capable of inducing TAT in fetal liver maintained 
in vitro, was added to cultures to facilitate detection of the 
enzyme.  Using this system, it has previously been demon- 
1. Abbreviations  used in this paper: GAPDH, glyceraldehyde-3-phosphate- 
dehydrogenase; TAT, tyrosine aminotransferase. 
strated  that  hepatocytes derived  from fetuses as young as 
16-d gestation possess TAT activity if placed in culture for 
1 d (36). 15-d gestation bepatocytes and younger do not have 
detectable levels of enzyme activity under similar conditions 
of culture. It was concluded in this study that hepatocytes at 
•16-d  gestation  undergo  a  differentiation  event  in  vivo 
resulting in the TAT gene becoming capable of expression. 
15-d fetal hepatocytes appear to be able to undergo this event 
when maintained in culture. Although enzyme activity is not 
detectable on the first day of culture, it is acquired by day 3. 
In this study, TAT gene expression in 15-d fetal hepatocytes 
maintained  in culture for 1, 2, or 3 d has been investigated 
with respect to enzyme synthesis,  mRNA levels, and gene 
transcription.  In  addition,  immunocytochemical  studies 
were undertaken to investigate events occurring at the cellu- 
lar  level.  Similar  biochemical  and  immunocytochemical 
measurements  in  13-  and  19-d gestation  hepatocytes,  de- 
velopmental ages both preceding and subsequent to the puta- 
tive differentiation event, have been included for comparison. 
Hepatocytes at all stages of gestation have been maintained 
in a constant environment with identical periods of exposure 
to dexamethasone at all time points.  In this way, it is con- 
cluded that the observed difference in TAT expression be- 
tween hepatocytes is an inherent property of the cell. 
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Animals 
Rats of the Wistar strain of Rattus norvegicus which have a 22-d gestation 
period were used. Gestational age was determined by vaginal smear to detect 
spermatozoa and is accurate to  +  8 h. 
Isolation and Culture of Fetal Hepatocytes 
Fetal hepatocytes used for culture were obtained from livers of 13-, 15-, or 
19-d gestation rats. Livers from 19-d gestation rats were incubated with col- 
lagenase (0.5  mg/ml balanced salts solution [15],  0.17 U/mg, Boehringer 
Mannheim, GmbH, FRG) for 15 rain at 37°C and prepared for culture as 
previously described (36). The isolation procedure for 15-d gestation livers 
involved a 5-min incubation with collagenase before being disaggregated by 
passage through a Pasteur pipette (8).  Cells isolated from the equivalent of 
seven livers were resuspended in 10 ml of medium. Livers from 13-d gesta- 
tion fetuses were removed by microscopic dissection techniques, treated 
with collagenase (0.5 mg/ml balanced salts solution [15], 80 livers/ml), pre- 
pared in the same manner as 15-d gestation hepatocytes and cells derived 
from  70  livers  resuspended  in  10  ml  of medium,  and  dispensed into 
collagen-coated culture dishes.  All fetal  hepatocytes were maintained in 
MEM supplemented with 10% FCS and antibiotics (36). Dexamethasone, 
prepared as a 1,000-fold stock solution in propyleneglycol, was added to he- 
patocyte cultures 18 h before harvesting or fixation to give a final concentra- 
tion of 10  -7 M. Hepatocytes not exposed to the glucocorticoid analogue re- 
ceived an equivalent volume of vehicle for the same time period. 
Enzyme Activity Assay 
To accurately measure TAT activity in fetal hepatocytes, it was necessary 
to first remove aspartate aminotransferase, an enzyme capable of tyrosine 
deamination, from cell extracts. Aspartate aminotransferase was separated 
chromatographically from TAT using CM-Sephadex C-50 (Pharmacia Fine 
Chemicals, Uppsala, Sweden) ion-exchange mini columns (36).  A radio- 
chemical method described previously (36) was then used to measure TAT 
activity  1 U catalyzed the formation of 1 /~mol of p-hydroxyphenylpyru- 
vate/h at  37°C.  The  DNA  content of the samples was measured by the 
fluorometric method of Hinegardner (17). 
TAT Synthesis and lmmunoprecipitation 
Hepatocyte cultures were incubated at 37°C in methionine-free medium for 
150 min before harvesting to diminish intracellular levels of methionine. Af- 
ter 60 rain of incubation, L-[35S]methionine (1,200 Ci/mmol; New England 
Nuclear, Boston, MA) was added to cultures. Subsequently, cells were har- 
vested, extracts prepared, and anti-TAT-precipitable polypeptides immuno- 
precipitated with specific antisera according to the method of Gross et al. 
(14) incorporating the modifications of Fletcher et al.  (8).  Immunocom- 
plexes were  analyzed by  SDS-PAGE in  slab gels (22)  and detected by 
fluorography as described by Bonner and Laskey (2). Bands corresponding 
to TAT, identified by fluorography, were cut from the gel, solubilized, and 
the radioactivity was determined by  liquid scintillation counting in a  /3 
counter (LS 3800;  Beckman Instruments, Inc., Palo Alto, CA). 
Preparation of Total RNA and Hybridization 
Total RNA was isolated from tissue or cell cultures by lithium chloride/urea 
extraction (24). For Northern analysis, 20 #g of RNA was electrophoresed 
in a 1.2% agarose gel containing 2.2 M formaldehyde (23) and electroblot- 
ted onto GeneScreen (New England Nuclear, Boston, MA) using a Trans- 
blot cell (Bio-Rad Laboratories, Richmond, CA). For dot blots, total RNA 
was denatured in 2.2 M formaldehyde, l M NaCI, 0.1 M tri-sodium citrate, 
pH 7.0, and blotted onto Hybond nylon transfer membrane (Amersham, 
Bucks, UK) TAT or glyceraldehyde-3-phosphate-dehydrogenase  (GAPDH) 
mRNA  was  detected  by  hybridization  with  peTAT-3  cDNA  (30)  or 
pRGAPDH-13  cDNA (9)  clones, respectively. These were labeled with 
deoxycytidine 5'-[ct-32p] triphosphate (3,000 Ci/mmol, Amersham) using a 
nick translation kit (Bethesda Research Laboratories, Gaithersburg, MD). 
Hybridization conditions included 50%  formamide, 5x  SSC, 0.1%  SDS, 
5x  Denhardt's solution (0.1%  Ficoll,  0.1%  polyvinylpyrrolidone, 0.1% 
BSA), and 250 #g/ml denatured salmon sperm DNA at 46°C for 36 h after 
an overnight prehybridization. Membranes were washed (10 min/wash) with 
vigorous agitation at room temperature (unless specified) with (a) 2×  SSC, 
0.1% SDS; (b) 0.5x SSC, 1% SDS at 65°C; and (c) 0.5x SSC, 0.1% SDS; 
and then exposed to X-ray film (RXO-H; Fuji, Haminex, Sydney, Australia) 
at  -70°C with an intensifying screen. 
"Run-on" Transcription in Isolated Nuclei 
and Hybridization 
Nuclei were isolated from fetal hepatocyte cultures by the method of Becker 
et al. (1), suspended in 60% glycerol, 4 mM MnCI2,  I mM MgC12, 5 mM 
DTT, 20 mM Tris, pH 7.4, and stored at -20°C. Transcription in isolated 
nuclei, isolation of 32P-labeled RNA, and hybridization to nitrocellulose 
filters were performed as described previously (5) with some modifications. 
Briefly,  isolated nuclei ("~107) were incubated in a reaction mixture con- 
sisting of 50 mM Hepes (pH 8.0),  150 mM NH4CI,  1 mg/ml BSA,  1 mM 
MnCI2,  12.5%  glycerol, 0.1 mg/ml heparin, 3.5 mM MgCI2,  1 p.1 (60 U) 
RNasin (Bochringer Mannheim GmbH),  0.25  mM  DTT,  0.5  mM ATE 
GTP,  CTP,  and UTE  100 #Ci of [ct-32P] UTP (3,1)00 Ci/mmol, Amer- 
sham) for 20 min at 25°C. The mixture was adjusted to final concentrations 
of 5  mM Tris (pH 7.5),  5  mM MgCI2,  and 5  mM CaCI2;  and  1U RQI 
DNase (Promega Biotec,  Madison, WI) was added and the mixture in- 
cubated for 5 min at 37°C.  After treatment with proteinase K (150 #g/ml) 
at 37°C for 30 min, RNA was isolated by phenol-chloroform extraction fol- 
lowed by TCA  precipitation and ethanol precipitation in the presence of 
0.05 mg/ml transfer RNA. After treating again with RQI DNase as above, 
RNA was isolated by phenol-chloroform extraction, collected by ethanol 
precipitation as above, and hybridized at 37°C for 72 h in 55 % formamide, 
4x  SSC, 0.1 M sodium phosphate (pH 6.8),  lx  Denhardt's solution, 0.1% 
SDS,  100 #g/ml salmon sperm DNA, and  10%  dextran sulphate to 0.25 
pmol of each of the following nitrocellulose-bound DNA: (a) TAT genomic 
subclones TAT EH 0.95, TAT EH 2.45, and TAT EE 1.05 (34); (b) albumin 
genomic subclones "B," "C," and "D" (29); (c) GAPDH cDNA pRGAPDH- 
13 (9); (d) phosphoenolpyruvate cDNA pPCK10 (38); (e) cDNA for mouse 
cq-antitrypsin (6); and (f) pUC8. Filters were washed at 65°C three times 
in lx SSC, 0.1% SDS (15 rain/wash) and then twice in 0.1x SSC, 0.1% SDS 
(45 min/wash) and associated radiolabel was visualized by fluorography and 
assessed by optical densitometry using a video densitometer-model 620; 
Bio-Rad  Laboratories.  Densitometric signals were converted to  relative 
transcription rates by subtracting the background signal (pUC8 signal) and 
correcting for the fraction of primary transcripts hybridizable to the recom- 
binant genomic DNA. Corrected values for albumin or TAT were normal- 
ized relative to the corrected pRGAPDH-13 signal for the respective filter. 
To enable an indirect comparison of transcription rates of TAT and albumin, 
the corrected and normalized values were divided by the respective gene 
length giving the relative proportion of transcripts produced per unit time 
from that gene, to the number of GAPDH transcripts produced per unit 
time. 
Immunocytochemistry 
Fetal  hepatocyte cultures were fixed in 4%  paraformaldehyde and 0.1% 
glutaraldehyde and stained for TAT as described (4),  with the following 
modifications: rabbit IgG specific for rat TAT or transferrin was diluted 
1:200 or  1:500 and peroxidase-coupled goat-Fab anti-rabbit IgG (Institut 
Pasteur, Marnes, France) diluted 1:200. Peroxidase activity was revealed by 
reaction with diaminobenzidine (0.5% in 0.05 M Tris, pH 7.5) in the pres- 
ence of 0.3%  H202  for 20 min at room temperature. Parallel incubations 
with IgG isolated from nonimmunized rabbits were included as negative 
controls. The number of hepatocytes expressing TAT were counted and ex- 
pressed as a percentage of the total number of hepatocytes. As ",,500 cells 
were counted per culture, and this relied upon identification of hepatocytes 
by light microscopy, the results can only be regarded as semiquantitative and 
approximate. 
Results 
It has previously been demonstrated that hepatocytes isolated 
from fetuses 16-d and older have low levels of TAT activity 
when maintained in culture; this activity is enhanced by ex- 
posure to dexamethasone (36). To facilitate detection of TAT, 
all hepatocytes in this study, unless otherwise noted, were 
exposed to maximally inducing levels of dexamethasone 18 
h before harvesting or fixation. Control cultures, which did 
not receive dexamethasone, were included in all experiments 
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thesis levels in 15 and 19 d fetal 
hepatocytes in culture. (a) Elec- 
trophoretic analysis of 35S-labeled 
TAT. After one, two, or three d in 
culture, hepatocytes  derived from 
15-d or  19-d gestation fetuses 
were incubated in the presence of 
L-[35S]methionine for  90  min, 
anti-TAT-precipitable polyt~tides 
immunoprecipitated  with specific 
antisem, analyzed by SDS-PAGE, 
and detected by fluorography as 
described in Materials and Meth- 
ods. A parallel incubation with 
nonimmune serum (NI) was in- 
clnded. The band corresponding 
to TAT, which is reported to have 
a  sub-unit molecular mass of 51 
kD (11), was identified by comparison with known J4C-methylated  protein standards: phosphorylase B (92.5 kD), BSA (69 kD), ovalbu- 
rain (46 kD), carbonic anhydrase (30 kD). (b) Hepatocytes derived from 15<1 (o) and 19-d (t~) gestation  rats were maintained  in culture 
for 1, 2, or 3 d and levels of TAT synthesis (o, m) and activity (o, D) measured. TAT activity is expressed as TAT U/rag DNA; synthesis 
is presented as dpm  ×  10-3/mg DNA. Data represents the mean +  standard error of six determinations. 
reported in this study, but the level of activity, mRNA, and 
staining by immunocytochemistry were always very low or 
undetectable. 
TAT Synthesis and Activity Levels 
Labeling experiments were performed to determine if TAT 
was synthesized in 15-d fetal hepatocytes on the first day of 
culture when enzyme activity is not detectable. As shown in 
the fluorograph (Fig.  1 a),  [35S]-labeled anti-TAT-precipit- 
able polypeptides were not observed in these hepatocytes on 
the first day of culture. However,  the radiolabeled product 
could be detected by days 2 and 3 and on each day of culture 
in 19-d gestation hepatocytes. Synthesis and activity levels 
in  15- and 19-d fetal hepatocytes maintained in culture for 
1, 2, or 3 d are presented in Fig.  1 b. TAT synthesis levels 
correlated with enzyme activity measurements for both 15- 
and 19-d fetal hepatocyte cultures. 
Steady-state TAT mRNA Levels 
To determine steady-state levels of TAT mRNA, total RNA 
was isolated from fetal hepatocyte cultures, electrophoresed 
on a denaturing gel, electroblotted, and hybridized with a 
specific TAT cDNA clone (Fig. 2 a). Blots were exposed for 
several days to detect low levels of  TAT mRNA. A single spe- 
cies of mRNA (2.4 kb) was revealed that appeared to be simi- 
lar in size to TAT mRNA isolated from adult liver. GAPDH 
served as an internal control to ensure that similar amounts 
of total RNA from fetal hepatocyte samples had been ana- 
lyzed. GAPDH mRNA levels did not differ appreciably be- 
tween fetal samples (Fig.  2 a).  Hepatocytes isolated from 
13-d  gestation rats did not have detectable levels of TAT 
mRNA on the first day of culture; very low levels could be 
observed by d 3.  15-d gestation hepatocytes had barely de- 
tectable levels of  TAT mRNA on the first day of culture; how- 
ever, these levels increased substantially when these hepato- 
cytes were maintained in culture for 2 or 3 d. In contrast to 
13- and 15-d gestation hepatocytes, TAT mRNA was present 
in 19-d gestation hepatocytes at appreciable levels on the first 
and subsequent days of  culture. By the second day of  culture, 
the accumulation of TAT mRNA in 19-d gestation hepato- 
cytes was estimated to be ,,o20% that of induced adult levels 
in vivo. TAT mRNA levels in 15- and 19-d gestation hepato- 
cyte cultures were analyzed by dot blot hybridization and 
results from a  representative experiment are presented in 
Fig. 2 b. Changes in TAT mRNA over the 3 d in culture were 
consistent with variations in TAT synthesis and activity dur- 
ing this time (Fig.  1 b). 
Transcription Measurements in Isolated Nuclei 
To determine whether the increase in steady-state levels of 
TAT mRNA in cultured fetal hepatocytes was due to altered 
stability of the mRNA or a change in the rate of transcription 
of  the gene, TAT transcription was analyzed by a run-on tran- 
scription assay. Hepatocytes from 15- or 19-d gestation hepa- 
tocytes were maintained in culture with or without exposure 
to dexamethasone. Nuclei were isolated and nascent RNA 
chains elongated in vitro in the presence of 32P-UTP. La- 
beled RNA was hybridized to excess single-copy DNA from 
various genes that had been immobilized on nitrocellulose 
filters.  A representative slot blot from one such experiment 
is illustrated in Fig. 3. Results, quantitated by densitometry, 
are presented in Table I. The relative rates of transcription 
of the TAT and albumin genes have been calculated relative 
to transcription of the constitutive gene GAPDH. 
Marginal levels of TAT mRNA detectable in control cul- 
tures of 19-d  gestation hepatocytes (data not shown) were 
reflected by low levels of transcription in these cells on the 
first and third day of culture. When 19-d gestation hepato- 
cytes were exposed to dexamethasone, TAT transcription was 
markedly enhanced on the first as well as third day of  culture. 
TAT transcription was not definitively detected in control 
cultures of 15-d gestation hepatocytes on the first day of cul- 
ture. Even after exposure to dexamethasone, hybridization to 
TAT DNA was not reproducibly greater than nonspecific hy- 
bridization to the vector DNA in these cells. However, when 
15-d gestation hepatocytes were maintained in culture for 3 d 
Shelly  et al. TAT Expression in Cultured  Fetal Rat Hepatocytes  3405 Figure 2. TAT mRNA levels in fetal hepatocytes in culture. (a) Total RNA (20 #g/lane) was isolated from 13-, 15-, or 19-d gestation hepato- 
cytes on the first, second, or third day of culture, electrophoresed in a  1.2%  agarose gel containing formaldehyde, electroblotted onto 
GeneSereen, and hybridized to 32p-labeled pcTAT-3 eDNA or pRGAPDH-13 eDNA as described in Materials and Methods. Adult liver 
RNA, prepared in the same manner as fetal samples, was isolated from rats that had been injected intraperitoneally with dexamethasone 
(10 mg/100 g body weight) 5 h before. Ribosomal RNA bands of 18 S and 28 S were used as standards. (b) Relative quantitation of TAT 
mRNA in 15-d ([]) or 19-d (I) gestation hepatocytes maintained in culture. Total RNA was isolated from fetal hepatoeytes on the first, 
second, and third day of culture, and analyzed by dot blot hybridization as described in Materials and Methods. TAT mRNA levels were 
quantitated by densitometry and values, the mean  +  standard error of at least three samples, are indicated in arbitrary units. Data was 
normalized relative to GAPDH and mRNA levels. 
and exposed to dexamethasone,  TAT transcription was  al- 
ways detected. The differences in hybridization signal inten- 
sity between nuclear transcripts from 15- and 19-d gestation 
hepatocytes after 1 and 3 d of culture corresponded to differ- 
ences seen in TAT mRNA levels at these times. These results 
indicate that TAT expression in cultured fetal hepatocytes ap- 
pears to be controlled primarily at the level of transcription 
and is not accounted for simply by a change in the stability 
of TAT mRNA. 
Albumin transcription was evident in control cultures of 
15- and  19-d gestation hepatocytes on each day of culture, 
and was enhanced by exposure to dexamethasone.  It is im- 
portant to note that unlike TAT gene transcription, the rela- 
Figure 3. Transcriptional analysis in nuclei isolated from  15- and 
19-d fetal hepatocytes in culture. Hepatocytes isolated from 15- or 
19-d gestation fetuses were maintained in culture for 1 d (Day 1 ) 
or 3 d (Day 3) with (Dex) or without (Con)  exposure to dexametha- 
sone as described in Materials and Methods. Nuclei were isolated, 
and nascent RNA chains were elongated in vitro and hybridized to 
immobilized DNA from the following genes: TAT, albumin (ALB), 
phosphoenolpyruvate earboxykinase (PEPCK), t~l-antitrypsin (ter 
AT), GAPDH, and pUC8. 
Table L  TATand Albumin Transcription in Isolated Nuclei 
Prepared  from Fetal Hepatocytes  in Culture 
Relative rate of~ 
Hybridization  signal*  transcription 
Vector 
Sample  signal  TAT  GAPDH  Albumin  TAT  Albumin 
15-d gestation  hepatocytes 
d  1 Con  0.06  0.01  0.89  2.26  0.01  0.47 
d  1 Dex  0.03  0.09  0.66  7.42  0.04  2.10 
d 3 Con  0.02  0.02  0.85  .81  0.01  0.18 
d 3 Dex  0.05  0.25  0.62  6.30  0.12  1.90 
19-d gestation hepatocytes 
d  1 Con  0.05  0.10  0.62  1.74  0.04  0.53 
d  1 Dex  0.15  1.06  0.75  9.07  0.40  2.25 
d 3 Con  0.06  0.20  0.95  0.36  0.06  0.07 
d 3 Dex  0.06  1.67  0.92  3.95  0.52  0.80 
All numerical values refer to optical density units. 
* Data has been corrected for nonspecific hybridization by subtraction of vec- 
tor signal. 
~: TAT and albumin densitometric  signals were corrected  for the fraction of 
primary gene transcripts hybridizable to the genomic DNA,  normalized rela- 
tive to GAPDH,  and converted to relative rates of transcription  as described 
in Materials and Methods. 
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ence ofdexamethasone on the first day of culture in 15-d fetal 
hepatocytes.  These  results  imply  that the changes  in TAT 
transcription  are specific. 
Iramunocytochemical Localization of 
I~rosine Aminotransferase 
TAT localization in 13-, 15-, and 194 gestation hepatocytes 
maintained in culture for 1, 2, or 3 d and exposed to dexa- 
methasone, was investigated using a peroxidase-labeled sec- 
ond antibody directed against rabbit IgG specific for rat TAT. 
The specificity of staining for TAT was demonstrated at both 
the electron (data not shown) and light microscope level. 
Brown reaction product, indicating the presence of TAT pro- 
tein,  was  localized  within  the  cytoplasm  of hepatocytes, 
never the nucleus or mitochondria.  Nonparenchymal cells, 
present between islands of hepatocytes, did not stain for ei- 
ther  TAT or transferrin  (Fig.  4  e-h). In  all  experiments, 
negligible  staining  was observed  when  IgG  from  nonim- 
munized rabbits was used in place of the primary antibody. 
134<1 gestation hepatocytes did not appear to have any TAT- 
expressing cells on the first day of culture (data not shown). 
A few TAT-positive cells (•1-2%)  could be identified when 
these hepatocytes were maintained in culture for 3 d (data not 
shown). When  15-d gestation hepatocytes were maintained 
in culture for 1 d, the occasional TAT-positive cell ("-,I-2 %, 
indicated by arrows) could be observed (Fig.  4, a  and b). 
This finding is in accordance with very low levels of TAT 
mRNA detectable in these cells at this stage of development. 
By day 2, the proportion of positive cells increased markedly, 
and small clusters and cords of these cells could be found ap- 
parently  randomly  distributed  among  the  cell  population 
(Fig. 4, c and d). At this time, these hepatocytes represented 
only a minor portion of the total population ("~8-12 %). Con- 
versely, immunocytochemical staining for transferrin in 15-d 
fetal hepatocytes maintained in culture for 2 d indicated that 
almost all hepatocytes expressed transferrin (Fig. 4, e and  f). 
Therefore  cells expressing  transferrin,  but not TAT,  were 
also considered to be hepatocytes. TAT expressing cells were 
found in 194 gestation hepatocytes maintained in culture for 
one (Fig. 4, g and h) or more days (data not shown), and ap- 
peared to represent a greater proportion  of the hepatocyte 
population (~15-18%) than observed in 2-d-old cultures de- 
rived from 154 gestation liver (Fig. 4, c and d). However, 
at no time in culture did all hepatocytes, either  15-or  19-d 
gestation, express the enzyme; an apparently heterogeneous 
labeling pattern was always observed. 
Discussion 
The fetal hepatocyte culture system provides a useful model 
to study the molecular mechanisms of TAT gene expression 
during development.  Although the TAT gene is potentially 
expressible in the fetus, expression is suppressed in the in 
utero environment. High circulating levels of insulin, known 
to be present in late gestation fetuses, have been implicated 
in suppression of TAT in utero (3, 18). By placing fetal hepa- 
tocytes in culture, thereby relieving restrictions imposed in 
vivo, it is possible to determine when the gene first becomes 
expressible during development. Experiments,  based on en- 
zyme  activity  measurements  in  fetal  hepatocyte  cultures 
(36), suggest that the gene can only be expressed from 164 
gestation onward. However, such studies do not preclude the 
possibility that the gene is, in fact, transcribed at an earlier 
stage of development. For example, the initial appearance of 
TAT activity may involve activation of an inactive precursor 
synthesized by immature hepatocytes. 
This study was undertaken to investigate TAT expression 
at the level of enzyme activity, protein synthesis, and mRNA, 
as  well as  transcription,  to  establish  the  critical  event(s) 
responsible for initiation of TAT expression. Transcription of 
the albumin gene was also assessed in nuclei isolated from 
different stages of development to serve as a control. Albu- 
min  transcription  was evident  in  control  cultures  derived 
from 15- and 194 gestation rats on both days 1 and 3. The 
relative rate of transcription  was enhanced in the presence 
of dexamethasone. 
Results from this study demonstrate that 154 fetal hepato- 
cytes acquire the capacity to express TAT when maintained 
in culture.  Enzyme activity and synthesis, absent on day 1, 
could be assayed by days 2 and 3. TAT mRNA and transcrip- 
tion were barely, if at all, detectable on the first day of culture 
but  increased  substantially  when  these  hepatocytes  were 
maintained  in culture for 2 and 3 d.  Unlike  15-d gestation 
hepatocytes, TAT activity and synthesis were evident on the 
first and subsequent days of culture in hepatocytes isolated 
from  194 gestation fetuses. This correlated with the pres- 
ence of TAT mRNA on each day of culture in these hepato- 
cytes,  although  levels  were considerably  lower than  TAT 
mRNA determinations  in induced adult liver. The increase 
in TAT mRNA in  15- and  194 gestation heptocytes main- 
tained in culture was proportional to changes in transcription 
of the gene indicating that TAT expression in fetal hepato- 
cytes maintained in vitro is controlled primarily at the level 
of transcription, as has been demonstrated for both intact and 
primary cultures of adult liver (16, 32) and the activation of 
TAT expression after birth (26). In view of these results, it 
is  proposed  that  15-d  gestation  hepatocytes  undergo  a 
differentiative event in culture such that the TAT gene be- 
comes capable of transcription.  Hepatocytes isolated from 
194 gestation fetuses appear to have already differentiated 
in vivo and are capable of TAT transcription when placed in 
culture. 
Unlike their more mature counterparts,  hepatocytes iso- 
lated from  13-d gestation fetuses did not have appreciable 
amounts of TAT mRNA, even after 3 d in culture. It is impor- 
tant to stress that in these experiments, hepatocytes derived 
from 13-, 15-, and 19-d gestation fetuses were maintained in 
a constant environment with identical periods of exposure to 
dexamethasone at all time points. The ability of the more ma- 
ture hepatocytes to express TAT would appear to be due to 
inherent differences between the cells, not the exposure to 
dexamethasone. It is unlikely that the absence of TAT expres- 
sion in immature hepatocytes reflects an inability of these he- 
patocytes to respond to glucocorticoids. This is supported by 
the finding that albumin transcription, unlike TAT transcrip- 
tion,  is  enhanced  by exposure  to dexamethasone  in  15-d 
gestation hepatocytes on the first day of culture,  suggesting 
that the machinery required for the glucocorticoid response 
is active. 
Studies of radiation-induced mutations in mice have estab- 
lished that the deletion of a region at and around the albino 
(c)  locus  in  chromosome  No.  7  affects  the  hormone- 
inducible expression of TAT as well as several other liver 
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a reduced level of TAT mRNA that is refractive to induction 
by either glucocorticoids or cAMP (31). It has been postu- 
lated that factor(s) encoded in the deleted region may be es- 
sential in conferring competence on the TAT structural gene 
to respond to these stimuli (7). The failure ofglucocorticoids 
to induce TAT in fetal liver was interpreted as a lack of com- 
petence of the TAT gene in prenatal hepatocytes to respond 
to the hormone. However,  results from this study indicate 
that the glucocorticoid analogue dexamethasone is capable 
of inducing TAT in hepatocytes as early as  15-d gestation 
when maintained in culture for 2 d. Furthermore, TAT activ- 
ity is enhanced by both glucocorticoids and cAMP in organ 
cultures of 16-d gestation liver (28).  On this basis,  if the 
trans-acting factor(s) confers competence on the TAT gene 
to respond to hormones, it would appear to be present in fetal 
liver from at least 16- or 17-d gestation. It remains to be elu- 
cidated whether this trans-acting factor(s) is involved in the 
initiation of TAT expression in  15-d gestation hepatocytes 
maintained in culture. 
The above biochemical measurements provided informa- 
tion about the cell population en masse. An immunocyto- 
chemical study was undertaken to investigate TAT localiza- 
tion at the cellular level. This study demonstrated that the 
increase  in  TAT  expression,  measured  by  biochemical 
means, was reflected by an increase in the proportion of he- 
patocytes expressing the enzyme, rather than a simultaneous 
increase in TAT expression in all hepatocytes. An increase 
in the amount of TAT synthesized per cell may also contrib- 
ute to the overall increase in expression. Very few cells ex- 
pressing TAT could be detected when 15-d gestation hepato- 
cytes were maintained in culture for 1 d, consistent with low 
levels of gene activity detected at this time. By day 2, the 
proportion of hepatocytes synthesizing the enzyme had in- 
creased. It is likely that these cells represented a population 
of  hepatocytes that differentiated in culture and in this respect 
became  capable  of expressing  TAT.  It  has  already been 
demonstrated that 19-d gestation hepatocytes are capable of 
TAT expression when placed in culture. Numerous TAT ex- 
pressing cells were evident when 19-d gestation hepatocytes 
were maintained in culture for 1 d, these presumably have 
undergone differentiation in vivo. 
Even after 3 d in culture, all hepatocytes derived from 19-d 
gestation  fetuses  did  not  express  the  enzyme  (data  not 
shown); a heterogeneous distribution pattern was observed. 
However it has been demonstrated that almost all hepatocytes 
are capable of expressing both albumin and transferrin from 
as early as 12-d gestation (21, 37). These findings lend sup- 
port to the proposal that the developing liver is comprised 
of subpopulations of hepatocytes, or compartments of cells, 
which can be characterized by differential expression of liver 
proteins such as TAT. Cells enter a compartment by undergo- 
ing a differentiative event thereby acquiring the ability to ex- 
press a new protein or proteins. In this way, hepatocytes are 
thought to transit from one compartment to the next during 
development  such  that  a  lineage  of hepatocytes  can  be 
demonstrated (36).  Myogenic and chrondrogenic lineages 
have been characterized whereby cells pass through consecu- 
tive compartments within their respective lineages resulting 
ultimately in terminally differentiated muscle cells or chon- 
drocytes (20).  In the case of TAT, hepatocytes appear to be 
recruited into the TAT compartment from ,'ol6-d gestation 
and this recruitment appears to occur in an asynchronous 
manner. 
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